Juno Pharmaceuticals Canada is pleased to announce the launch of our latest product, Eptifibatide for injection which is available at your local Canadian wholesalers!

Eptifibatide is used for the treatment of patients presenting with symptoms of unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI), including those patients who may subsequently undergo percutaneous coronary intervention (PCI) as well as those who will be managed medically.